Managing pulmonary embolism using prognostic models: future concepts for primary care

Geersing, Geert‐Jan; Oudega, Ruud; Hoes, Arno W.; Moons, Karel G.M.

doi:10.1503/cmaj.110213

Cited by 3 publications

(2 citation statements)

References 44 publications

(42 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In individuals using vitamin K antagonists, this frequently necessitates monitoring the international normalized ratio, ensuring that low-molecular-weight heparin is delivered subcutaneously for at least five days, as well as a five-day course of low-molecular-weight heparin. And early detection of therapy failure, such as recurrent pulmonary embolism or hemorrhage, with required hospital readmission [9]. There were 1021 people who had deep vein thrombosis or pulmonary embolism were studied was analyzed by Douketis and colleagues (2010) to determine the factors that contribute to treatment failure.…”

Section: Prognostic Ratings For Short-term Risk Guiding Practicementioning

confidence: 99%

See 1 more Smart Citation

Primary Care in Management of Pulmonary Embolism in Prolonged Recumbences

Mohammad Alsudairy,

Abdullah AL Qurain,

Fatemah Salman R Alhadab

et al. 2023

SMHJ

View full text Add to dashboard Cite

A frequent and possibly fatal kind of venous thromboembolic illness is pulmonary embolism (PE). It is a significant issue for public health. A typical diagnosis as a primary care in an emergency room is pulmonary embolism (PE). Additionally, it makes up a sizable portion of the patients admitted to hospital wards. In selected low-risk individuals with acute PE, there is mounting evidence that outpatient therapy, or treatment without hospitalization, is practical, safe, and efficient. PE patients may be risk-classified and given an early release from the emergency department. As a result, there are more hospital beds available for other patients, which lowers treatment expenses for the healthcare system. There is growing support for the outpatient care of low-risk, hemo-dynamically stable patients with acute symptomatic pulmonary embolism (PE). There is assistance in identifying patients who are eligible for outpatient (primary) care. This move has been made easier by the accessibility and simplicity of direct oral anticoagulants. Acute PE is currently mostly treated with direct, non-vitamin K-dependent oral anticoagulants. In comparison to vitamin K antagonists, they have been demonstrated to simplify initial and prolonged anticoagulation regimes while lowering the risk of bleeding. In this consensus practice document, we present a thorough analysis of primary care in the diagnosis, treatment, and follow-up of acute PE.

show abstract

Section: Prognostic Ratings For Short-term Risk Guiding Practicementioning

confidence: 99%

“…Additionally, we now understand that pulmonary embolism does not always take the dramatic path of hemodynamic instability and shock, with a high risk of death if treatment is not started right away. Finding individuals with low mortality risk may open up the possibility of outpatient care in a primary care environment [9].…”

Section: Introductionmentioning

confidence: 99%